| Real-time, portable genome sequencing for Ebola surveillance J Quick, NJ Loman, S Duraffour, JT Simpson, E Severi, L Cowley, JA Bore, ... Nature 530 (7589), 228-232, 2016 | 1503 | 2016 |
| Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ... bmj 370, 2020 | 1035 | 2020 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 925 | 2022 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 741 | 2021 |
| Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study OV Swann, KA Holden, L Turtle, L Pollock, CJ Fairfield, TM Drake, S Seth, ... bmj 370, 2020 | 718 | 2020 |
| Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa MW Carroll, DA Matthews, JA Hiscox, MJ Elmore, G Pollakis, A Rambaut, ... Nature 524 (7563), 97-101, 2015 | 370 | 2015 |
| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 294 | 2021 |
| Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study TM Drake, AB Docherty, EM Harrison, JK Quint, H Adamali, S Agnew, ... American journal of respiratory and critical care medicine 202 (12), 1656-1665, 2020 | 224 | 2020 |
| Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... The Lancet Respiratory Medicine 9 (4), 349-359, 2021 | 212 | 2021 |
| Unique human immune signature of Ebola virus disease in Guinea P Ruibal, L Oestereich, A Lüdtke, B Becker-Ziaja, DM Wozniak, R Kerber, ... Nature 533 (7601), 100-104, 2016 | 183 | 2016 |
| Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the … CI Bloom, TM Drake, AB Docherty, BJ Lipworth, SL Johnston, ... The Lancet Respiratory Medicine 9 (7), 699-711, 2021 | 170 | 2021 |
| A prenylated dsRNA sensor protects against severe COVID-19 A Wickenhagen, E Sugrue, S Lytras, S Kuchi, M Noerenberg, ML Turnbull, ... Science 374 (6567), eabj3624, 2021 | 151 | 2021 |
| Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus X Liu, E Speranza, C Muñoz-Fontela, S Haldenby, NY Rickett, ... Genome biology 18, 1-17, 2017 | 149 | 2017 |
| Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study TM Drake, AM Riad, CJ Fairfield, C Egan, SR Knight, R Pius, ... The Lancet 398 (10296), 223-237, 2021 | 147 | 2021 |
| Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19 FJ Salguero, AD White, GS Slack, SA Fotheringham, KR Bewley, ... Nature Communications 12 (1), 1260, 2021 | 127 | 2021 |
| Elucidation of the Ebola virus VP24 cellular interactome and disruption of virus biology through targeted inhibition of host-cell protein function I García-Dorival, W Wu, S Dowall, S Armstrong, O Touzelet, J Wastling, ... Journal of proteome research 13 (11), 5120-5135, 2014 | 101 | 2014 |
| Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK AB Docherty, RH Mulholland, NI Lone, CP Cheyne, D De Angelis, ... The Lancet Respiratory Medicine 9 (7), 773-785, 2021 | 99 | 2021 |
| Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study TM Drake, CJ Fairfield, R Pius, SR Knight, L Norman, M Girvan, ... The Lancet Rheumatology 3 (7), e498-e506, 2021 | 87 | 2021 |
| Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 CP Thompson, NE Grayson, RS Paton, JS Bolton, J Lourenço, ... Eurosurveillance 25 (42), 2000685, 2020 | 79 | 2020 |
| SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ... EBioMedicine 87, 2023 | 71 | 2023 |
